CD47 and neoplasm: For CD47 CPS, there was a significant difference in NAC between the high- and low-expression groups (P = 0.011), and for CD47 TPS, significant differences were observed in clinical tumor stage (T) and NAC between the high- and low-expression groups (P = 0.046 and 0.049, respectively).